Hotamisligil graduated from Ankara University, Medical School in 1986 and completed his specialty training and dissertation studies in Biological Chemistry and Molecular Genetics at Harvard University. He is currently the J.S. Simmons Professor of Genetics and Metabolism, Chair of the Department of Genetics and Complex Diseases and Sabri Ülker Center. His seminal discoveries and innovative work has opened up new fields of study on fundamental mechanisms related to metabolic diseases and recognized by many distinctions including Markey and Pew Fellowships, TUBITAK Science Award, Outstanding Scientific Accomplisment Award of American Diabetes Association, Naomie Berrie, Wertheimer and Roy Greep Awards and Danone International Nutrition Prize. He is elected member of Turkish Academy of Sciences and elected fellow of AAAS and serves on the Board of Directors of Kadir Has University. Hotamışlıgil’s discoveries have introduced new concepts for diabetes, obesity, atherosclerosis and fatty liver disease and inspired many drug development programs. Through multiple industry-academia partnership programs, Hotamışlıgil continues to pursue preventive and therapeutic solutions for common metabolic diseases.
